Author

Aleksander Prejbisz

h-index 4 View on Semantic Scholar

We have 4 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Clinical significance of lipoprotein(a) in patients hospitalized with acute coronary syndromes: a contemporary real-world cohort study

Lipoprotein(a) [Lp(a)] is an established genetically determined cardiovascular risk factor; however, comprehensive real-world data on its distribution and clinical significance in patients hospitalized with acute coronary syndromes (ACS) remain limited. We aimed to characterize Lp(a) concentrations in a contempor...

Michał Miszczak, Beata Mokrauz, P. Piwowarczyk et al. · BMC Cardiovascular Disorders · 0 citations

Open access Sep 2026

Association of lipoprotein(a) with the angiographic extent of coronary artery disease and selected angiographic findings in patients with acute coronary syndromes.

Elevated Lp(a) concentrations were independently associated with the angiographic extent of coronary artery disease in patients with acute coronary syndromes, including multivessel disease and chronic total occlusions, including multivessel disease and chronic total occlusions.

Michał Miszczak, Beata Mokrauz, P. Piwowarczyk et al. · Atherosclerosis Plus · 0 citations

Review Open access Jul 2026

Short sleep, lifestyle, cardiovascular risk, and health awareness among Polish final-year secondary school students: findings from a nationwide study

Insufficient sleep is common among Polish young adults and is associated with an unfavorable behavioral and cardiometabolic risk profile.

Dorota Godzina, A. Doryńska, Ludmiła Podgórska-Stawiecka et al. · Frontiers in sleep · 0 citations

Review Open access Aug 2026

Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives

Lp(a) may soon shift from a “silent threat” to a precise, actionable target in cardiovascular prevention, according to a review of the current evidence, which highlights gaps in knowledge, and discusses emerging therapeutic strategies.

Michał Miszczak, P. Piwowarczyk, G. Sobieszek et al. · Biomedicines · 0 citations